MTNB – Matinas Biopharma Holdings Inc
Matinas Biopharma Holdings, IncMTNB
$0.6Name : Matinas Biopharma Holdings, Inc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $3,052,188.00
EPSttm : -4.98
Matinas Biopharma Holdings, Inc
$0.6
6.19%$0.035Float Short %
4.37
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
1.5
Price
0.6
Target Price
30
Analyst Recom
2
Performance Q
7.87
Relative Volume
0.14
Beta
1.12
Ticker: MTNB
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-03-20 | MTNB | 0.541 | N/A | N/A | 0 |
| 2025-03-21 | MTNB | 0.5999 | N/A | N/A | 0 |
| 2025-03-24 | MTNB | 0.5997 | N/A | N/A | 0 |
| 2025-03-25 | MTNB | 0.58 | N/A | N/A | 0 |
| 2025-03-26 | MTNB | 0.5707 | N/A | N/A | 0 |
| 2025-03-27 | MTNB | 0.565 | N/A | N/A | 0 |
| 2025-03-28 | MTNB | 0.545 | N/A | N/A | 0 |
| 2025-03-31 | MTNB | 0.5291 | N/A | N/A | 0 |
| 2025-04-01 | MTNB | 0.546 | N/A | N/A | 0 |
| 2025-04-02 | MTNB | 0.57 | N/A | N/A | 0 |
| 2025-04-03 | MTNB | 0.537 | N/A | N/A | 0 |
| 2025-04-04 | MTNB | 0.55 | N/A | N/A | 0 |
| 2025-04-07 | MTNB | 0.5035 | N/A | N/A | 0 |
| 2025-04-08 | MTNB | 0.4911 | N/A | N/A | 0 |
| 2025-04-09 | MTNB | 0.525 | N/A | N/A | 0 |
| 2025-04-10 | MTNB | 0.52 | N/A | N/A | 0 |
| 2025-04-11 | MTNB | 0.5259 | N/A | N/A | 0 |
| 2025-04-14 | MTNB | 0.557 | N/A | N/A | 0 |
| 2025-04-15 | MTNB | 0.5627 | N/A | N/A | 0 |
| 2025-04-16 | MTNB | 0.5879 | N/A | N/A | 0 |
| 2025-04-17 | MTNB | 0.58 | N/A | N/A | 0 |
| 2025-04-18 | MTNB | 0.6 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-03-20 | MTNB | 0.54 | 48.0 | - | -4.06 |
| 2025-03-21 | MTNB | 0.59 | 48.0 | - | -4.06 |
| 2025-03-24 | MTNB | 0.60 | 48.0 | - | -4.06 |
| 2025-03-25 | MTNB | 0.56 | 48.0 | - | -4.06 |
| 2025-03-26 | MTNB | 0.57 | 48.0 | - | -4.06 |
| 2025-03-27 | MTNB | 0.56 | 48.0 | - | -4.06 |
| 2025-03-28 | MTNB | 0.54 | 48.0 | - | -4.06 |
| 2025-03-31 | MTNB | 0.52 | 48.0 | - | -4.06 |
| 2025-04-01 | MTNB | 0.57 | 48.0 | - | -4.06 |
| 2025-04-02 | MTNB | 0.56 | 48.0 | - | -4.06 |
| 2025-04-03 | MTNB | 0.55 | 48.0 | - | -4.06 |
| 2025-04-04 | MTNB | 0.54 | 48.0 | - | -4.06 |
| 2025-04-07 | MTNB | 0.54 | 48.0 | - | -4.06 |
| 2025-04-08 | MTNB | 0.51 | 48.0 | - | -4.06 |
| 2025-04-09 | MTNB | 0.52 | 48.0 | - | -4.06 |
| 2025-04-10 | MTNB | 0.51 | 48.0 | - | -4.06 |
| 2025-04-11 | MTNB | 0.53 | 48.0 | - | -4.06 |
| 2025-04-14 | MTNB | 0.58 | 48.0 | - | -4.06 |
| 2025-04-15 | MTNB | 0.58 | 48.0 | - | -4.06 |
| 2025-04-16 | MTNB | 0.58 | 48.0 | - | -4.06 |
| 2025-04-17 | MTNB | 0.60 | 48.0 | - | -4.06 |
| 2025-04-18 | MTNB | 0.60 | 48.0 | - | -1.50 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-03-20 | MTNB | 0.00 | -61.76 | 8.69 |
| 2025-03-21 | MTNB | 0.00 | -61.76 | 8.69 |
| 2025-03-24 | MTNB | 0.00 | -61.76 | 8.69 |
| 2025-03-25 | MTNB | 0.00 | -61.76 | 8.69 |
| 2025-03-26 | MTNB | 0.00 | -61.76 | 5.10 |
| 2025-03-27 | MTNB | 0.00 | -61.76 | 5.10 |
| 2025-03-28 | MTNB | 0.00 | -61.76 | 5.10 |
| 2025-03-31 | MTNB | 0.00 | -61.02 | 5.10 |
| 2025-04-01 | MTNB | 0.00 | -61.02 | 5.10 |
| 2025-04-02 | MTNB | 0.00 | -61.02 | 5.10 |
| 2025-04-03 | MTNB | 0.00 | -61.02 | 5.10 |
| 2025-04-04 | MTNB | 0.00 | -61.02 | 5.10 |
| 2025-04-07 | MTNB | 0.00 | -61.02 | 5.10 |
| 2025-04-08 | MTNB | 0.00 | -61.02 | 5.10 |
| 2025-04-09 | MTNB | 0.00 | -61.02 | 5.10 |
| 2025-04-10 | MTNB | 0.00 | -61.02 | 4.37 |
| 2025-04-11 | MTNB | 0.00 | -61.02 | 4.37 |
| 2025-04-14 | MTNB | 0.00 | -61.02 | 4.37 |
| 2025-04-15 | MTNB | 0.00 | -61.02 | 4.37 |
| 2025-04-16 | MTNB | 0.00 | -61.02 | 4.37 |
| 2025-04-17 | MTNB | 0.00 | -61.02 | 4.37 |
| 2025-04-18 | MTNB | 0.00 | -61.02 | 4.37 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.78
Avg. EPS Est. Next Quarter
Insider Transactions
Institutional Transactions
-61.02
Beta
1.12
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
4
Growth Score
21
Sentiment Score
76
Actual DrawDown %
99.5
Max Drawdown 5-Year %
-99.4
Target Price
30
P/E
Forward P/E
PEG
P/S
P/B
0.4
P/Free Cash Flow
EPS
-4.99
Average EPS Est. Cur. Y
-1.5
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.14
Return on Equity vs Sector %
-153.9
Return on Equity vs Industry %
-140.5
EPS 1 7Days Diff
2.8
EPS 1 30Days Diff
3
EBIT Estimation
Matinas Biopharma Holdings, IncSector: Healthcare
Industry: Biotechnology
Employees: 32
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is MAT2203, an oral formulation of amphotericin B that is starting Phase 3 clinical trials for the treatment of aspergillosis and cryptococcosis, as well as prevention of invasive fungal infections in patients due to immunosuppressive therapy. It also offers MAT2501, an orally administered formulation of amikacin to treat chronic and acute bacterial infections, as well as non-tuberculosis mycobacterium. The company has strategic collaborations with the National Institute of Allergy and Infectious Diseases for the development of oral formulations of Gilead's remdesivir; BioNTech SE to evaluate the combination of mRNA formats with the LNC platform; and Genentech Inc. to develop oral formulations. Matinas BioPharma Holdings, Inc. was incorporated in 2013 and is based in Bedminster, New Jersey.
stock quote shares MTNB – Matinas Biopharma Holdings Inc Stock Price stock today
news today MTNB – Matinas Biopharma Holdings Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MTNB – Matinas Biopharma Holdings Inc yahoo finance google finance
stock history MTNB – Matinas Biopharma Holdings Inc invest stock market
stock prices MTNB premarket after hours
ticker MTNB fair value insiders trading